NO881515L - Pulmonar surfaktant. - Google Patents

Pulmonar surfaktant.

Info

Publication number
NO881515L
NO881515L NO88881515A NO881515A NO881515L NO 881515 L NO881515 L NO 881515L NO 88881515 A NO88881515 A NO 88881515A NO 881515 A NO881515 A NO 881515A NO 881515 L NO881515 L NO 881515L
Authority
NO
Norway
Prior art keywords
surfactant
pulmonar
adul
irds
ards
Prior art date
Application number
NO88881515A
Other languages
English (en)
Other versions
NO174733C (no
NO881515D0 (no
NO174733B (no
Inventor
Bengt Robertson
Tore Curstedt
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of NO881515D0 publication Critical patent/NO881515D0/no
Publication of NO881515L publication Critical patent/NO881515L/no
Publication of NO174733B publication Critical patent/NO174733B/no
Publication of NO174733C publication Critical patent/NO174733C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/42—Respiratory system, e.g. lungs, bronchi or lung cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0082—Lung surfactant, artificial mucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Physiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
NO881515A 1987-04-08 1988-04-07 Fremgangsmåte ved fremstilling av pulmonar surfaktant NO174733C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8720032A IT1203873B (it) 1987-04-08 1987-04-08 Composizioni farmaceutiche che lo surfattante polmonare naturale, contengono. metodo di preparazione e

Publications (4)

Publication Number Publication Date
NO881515D0 NO881515D0 (no) 1988-04-07
NO881515L true NO881515L (no) 1988-10-10
NO174733B NO174733B (no) 1994-03-21
NO174733C NO174733C (no) 1994-06-29

Family

ID=11163272

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881515A NO174733C (no) 1987-04-08 1988-04-07 Fremgangsmåte ved fremstilling av pulmonar surfaktant

Country Status (22)

Country Link
US (1) US5024995A (no)
EP (1) EP0286011B1 (no)
JP (1) JP2700323B2 (no)
AT (1) ATE99949T1 (no)
AU (1) AU619462B2 (no)
CA (1) CA1320440C (no)
DE (2) DE286011T1 (no)
DK (1) DK172921B1 (no)
EG (1) EG19626A (no)
ES (1) ES2004856T3 (no)
FI (1) FI92905C (no)
GR (1) GR890300026T1 (no)
HK (1) HK1007103A1 (no)
HU (1) HU211950A9 (no)
IE (1) IE61384B1 (no)
IT (1) IT1203873B (no)
MY (1) MY103260A (no)
NO (1) NO174733C (no)
NZ (1) NZ224146A (no)
PH (1) PH25300A (no)
PT (1) PT87188B (no)
ZA (1) ZA882416B (no)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8803713D0 (sv) * 1988-10-18 1988-10-18 Kabigen Ab Biologically active lipoprotein and its use
DE3921954A1 (de) * 1989-07-04 1991-01-17 Thomae Gmbh Dr K Niedrig-viskose, hochkonzentrierte surfactant-suspension
DE69131163T2 (de) * 1990-05-18 1999-12-23 Tokyo Tanabe Co Asthma heilmittel
US5437272A (en) * 1991-05-01 1995-08-01 Alliance Pharmaceutical Corp. Perfluorocarbon associated gas exchange
JP2607021B2 (ja) 1991-05-03 1997-05-07 アライアンス ファーマシューティカル コーポレイション フルオロカーボンの部分液体呼吸
ES2118836T3 (es) * 1991-11-14 1998-10-01 Alliance Pharma Procedimiento y aparato de ventilacion parcial con liquidos usando fluorocarburos.
IT1255967B (it) * 1992-11-27 1995-11-17 Chiesi Farma Spa Procedimento per la purificazione di materiale surfattante polmonare naturale con l'impiego di fluidi supercritici
US5531219A (en) * 1994-11-04 1996-07-02 Alliance Pharmaceutical Corp. Use of liquid fluorocarbons to facilitate pulmonary drug delivery
CO5021218A1 (es) * 1994-12-29 2001-03-27 Ct Nac De Sanidad Agropecuaria Surfactante pulmonar natural porcino
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
US6172203B1 (en) * 1996-02-07 2001-01-09 Alfredo Adolfo Hager Method for extracting and purifying pulmonary surfactant
WO1997029738A1 (en) * 1996-02-16 1997-08-21 The Administrators Of The Tulane Educational Fund Methods and compositions for treating eustachian tube dysfunction by inhalation
AU6083899A (en) 1999-09-16 2001-04-17 Aventis Behring Gmbh Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
US6156294A (en) 1999-11-28 2000-12-05 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
US6676930B2 (en) 1999-11-28 2004-01-13 Scientific Development And Research, Inc. Composition and method for treatment of otitis media
DE19957898A1 (de) * 1999-12-01 2001-06-07 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant
DE10018022A1 (de) * 2000-04-12 2001-10-31 Byk Gulden Lomberg Chem Fab Neue Verwendung von Lungensurfactant zur Prophylaxe oder Frühbehandlung von akuten Lungenerkrankungen
ES2346048T3 (es) 2001-10-11 2010-10-08 Nycomed Gmbh Nueva utilizacion de un agente tensioactivo pulmonar.
US8236750B2 (en) 2004-08-06 2012-08-07 Nycomed Gmbh Composition comprising a pulmonary surfactant and a TNF-derived peptide
US7582312B2 (en) 2004-11-15 2009-09-01 Discovery Laboratories, Inc. Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
US8337815B2 (en) * 2004-12-23 2012-12-25 Discovery Laboratories, Inc. Pulmonary surfactant formulations
PL1841458T3 (pl) 2005-01-06 2012-05-31 Discovery Lab Inc Schemat stosowania środka powierzchniowo czynnego do leczenia lub zapobiegania dysplazji oskrzelowo-płucnej
GB2426703B (en) * 2005-05-31 2007-09-19 Malvern Cosmeceutics Ltd Compositions
AU2007297691B2 (en) * 2006-09-19 2013-12-19 Discovery Laboratories, Inc. Pulmonary surfactant formulations and methods for promoting mucus clearance
US7951781B2 (en) 2006-11-02 2011-05-31 University Of Iowa Research Foundation Methods and compositions related to PLUNC surfactant polypeptides
DE102007025898A1 (de) * 2007-06-01 2008-12-04 Matthias W. Dr. Amrein Behandlung von Surfactanten
AU2009324637B2 (en) 2008-12-10 2016-09-08 Paka Pulmonary Pharmaceuticals, Inc. Methods and compositions for delivery of medicaments to the lungs
WO2019009628A2 (ko) * 2017-07-07 2019-01-10 주식회사 리포바이오랩 화상 및 욕창의 완화 및 치료용 조성물
US11219843B2 (en) * 2019-07-08 2022-01-11 Nik Paya Karen Pharmed Extraction of animal-derived pulmonary surfactants
AR126368A1 (es) 2021-07-05 2023-10-11 Chiesi Farm Spa Proceso para la preparación de un tensioactivo pulmonar

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55160721A (en) * 1979-06-02 1980-12-13 Tokyo Tanabe Co Ltd Pulmonary surfactant ta-546, its preparation, and remedy for pulmonary hyaline membrane syndrome comprising it as active constituent
US4312860A (en) * 1980-10-24 1982-01-26 Regents Of The University Of California Lung surfactant compositions
JPS5845299A (ja) * 1981-09-10 1983-03-16 東京田辺製薬株式会社 新規な表面活性物質、その製造法及びそれを含有する呼吸窮迫疾候群治療剤
JPS58222022A (ja) * 1982-06-21 1983-12-23 Teijin Ltd 合成肺表面活性剤及びそれを有効成分とする呼吸窮迫症候群治療剤
JPS59164724A (ja) * 1983-03-10 1984-09-17 Tokyo Tanabe Co Ltd サ−フアクタント及びそれを含有する呼吸窮迫症候群治療剤
BG49073A1 (en) * 1983-12-08 1991-08-15 Dresden Arzneimittel Remedy for treatment of asthmatic syndrome caused by lack of surface- active substance and method for obtaining it
JPS6165821A (ja) * 1984-09-07 1986-04-04 Tokyo Tanabe Co Ltd 合成サ−フアクタント及びそれを有効成分とする肺表面活性物質喪失性無気肺の治療剤
FR2586587B1 (fr) * 1985-08-30 1987-10-23 Adir Nouveaux surfactants artificiels, leur preparation et les compositions pharmaceutiques qui les contiennent.
JPS63503222A (ja) * 1986-05-06 1988-11-24 サイオス　ノバ　インコーポレイテッド 肺の疎水性界面活性物質に結合した分子量６，０００ダルトンのタンパク質及びその多量体

Also Published As

Publication number Publication date
ZA882416B (en) 1988-09-28
DK190088D0 (da) 1988-04-07
DE3886970D1 (de) 1994-02-24
ATE99949T1 (de) 1994-01-15
FI92905C (fi) 1995-01-25
HU211950A9 (en) 1996-01-29
FI881508A (fi) 1988-10-09
FI92905B (fi) 1994-10-14
DE3886970T2 (de) 1994-05-26
ES2004856T3 (es) 1994-12-16
JP2700323B2 (ja) 1998-01-21
MY103260A (en) 1993-05-29
IE881008L (en) 1988-10-08
EP0286011A2 (en) 1988-10-12
JPS6463526A (en) 1989-03-09
AU1433788A (en) 1988-10-13
IT1203873B (it) 1989-02-23
NO174733C (no) 1994-06-29
NO881515D0 (no) 1988-04-07
US5024995A (en) 1991-06-18
NO174733B (no) 1994-03-21
FI881508A0 (fi) 1988-03-30
HK1007103A1 (en) 1999-04-01
IT8720032A0 (it) 1987-04-08
ES2004856A4 (es) 1989-02-16
DK190088A (da) 1988-10-09
EP0286011B1 (en) 1994-01-12
PH25300A (en) 1991-04-30
EG19626A (en) 1995-09-30
CA1320440C (en) 1993-07-20
EP0286011A3 (en) 1990-02-07
PT87188A (pt) 1988-05-01
PT87188B (pt) 1992-07-31
IE61384B1 (en) 1994-11-02
GR890300026T1 (en) 1989-04-12
DK172921B1 (da) 1999-10-04
AU619462B2 (en) 1992-01-30
NZ224146A (en) 1991-06-25
DE286011T1 (de) 1989-03-09

Similar Documents

Publication Publication Date Title
NO881515L (no) Pulmonar surfaktant.
SE7904010L (sv) Sett att utvinna protein ur vassla
EP0156961A3 (en) Process for preparing highly purified, stroma-free and hepatitis-resisting human and animal haemoglobin solutions
ATE114156T1 (de) Herstellung von proteinen in aktiver form.
DK616887D0 (da) Fremgangmaade til behandling af valle-proteiner
EP0311283A3 (en) Process for obtaining concentrates having a high alpha-lactalbumin content from whey
DK644388A (da) Farmaceutiske praeparater indeholdende 3-hydroxy-smoeresyrederivater
DE69129747T2 (de) In lösung bringen von proteinen in aktiver form
IL90508A0 (en) Amblyommin,a new active substance for anticoagulant therapy
DE3466695D1 (en) Process for the preparation of globin from hemoglobin, and globin obtained in this process
DE68913386D1 (de) Selektive enzymatische Zersetzung von beta-Lactoglobulin in Molkeeiweiss von Kuhmilch.
IT8223609A0 (it) Procedimento per l'estrazione di sostanze azotate, in particolare proteine e/o amminoacidi da sostanze vegetali, in particolare da sottoprodotti della lavorazione della soia.
JPS56113710A (en) Preparation of prolonged action composition substance
ATE96618T1 (de) Molkeproteinfraktionen.
IT9047803A0 (it) Procedimento per la separazione e il recupero delle proteine del sierodel latte.

Legal Events

Date Code Title Description
MK1K Patent expired